Puri Michal Nath (CIK 1997032) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy NVCR (1,905 shares), Buy NVCR (40,100 shares), Sell NVCR (1,100 shares), Sell NVCR (1,441 shares), Buy NVCR (1 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | NovoCure Ltd (NVCR) | Chief Human Resources Officer | Buy | 1,905 | $21,241 |
| 2026-03-05 | NovoCure Ltd (NVCR) | Chief Human Resources Officer | Buy | 40,100 | $0 |
| 2026-03-05 | NovoCure Ltd (NVCR) | Chief Human Resources Officer | Sell | 1,100 | $14,641 |
| 2026-03-03 | NovoCure Ltd (NVCR) | Chief Human Resources Officer | Sell | 1,441 | $19,684 |
| 2026-01-08 | NovoCure Ltd (NVCR) | Chief Human Resources Officer | Buy | 1 | $11 |
| 2025-11-04 | NovoCure Ltd (NVCR) | Chief Human Resources Officer | Sell | 752 | $9,641 |
| 2025-07-01 | NovoCure Ltd (NVCR) | Chief Human Resources Officer | Buy | 833 | $12,603 |
来源：SEC Form 4 申报文件 · 截至 2026-07-01